Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP814638.RANC-Zikph76CyxuRqCj_FWUNLUZo8CAar5e7-a2YzKM0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP814638.RANC-Zikph76CyxuRqCj_FWUNLUZo8CAar5e7-a2YzKM0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP814638.RANC-Zikph76CyxuRqCj_FWUNLUZo8CAar5e7-a2YzKM0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP814638.RANC-Zikph76CyxuRqCj_FWUNLUZo8CAar5e7-a2YzKM0130_provenance.
- NP814638.RANC-Zikph76CyxuRqCj_FWUNLUZo8CAar5e7-a2YzKM0130_assertion wasGeneratedBy ECO_0000203 NP814638.RANC-Zikph76CyxuRqCj_FWUNLUZo8CAar5e7-a2YzKM0130_provenance.
- NP814638.RANC-Zikph76CyxuRqCj_FWUNLUZo8CAar5e7-a2YzKM0130_assertion wasDerivedFrom befree-20140225 NP814638.RANC-Zikph76CyxuRqCj_FWUNLUZo8CAar5e7-a2YzKM0130_provenance.
- NP814638.RANC-Zikph76CyxuRqCj_FWUNLUZo8CAar5e7-a2YzKM0130_assertion SIO_000772 18974277 NP814638.RANC-Zikph76CyxuRqCj_FWUNLUZo8CAar5e7-a2YzKM0130_provenance.
- NP814638.RANC-Zikph76CyxuRqCj_FWUNLUZo8CAar5e7-a2YzKM0130_assertion evidence source_evidence_literature NP814638.RANC-Zikph76CyxuRqCj_FWUNLUZo8CAar5e7-a2YzKM0130_provenance.
- NP814638.RANC-Zikph76CyxuRqCj_FWUNLUZo8CAar5e7-a2YzKM0130_assertion description "[Treatment with Rottlerin, a PKC-delta isoform inhibitor, reduced significantly the glucose-induced ET-1 secretion, and ECE-1 protein expression, but (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno 1H,1(3)H-dibenzo[e,k]pyrrolo[3,4-h] (1, 4, 3) oxadiaza-cyclohexadecene-1,3(2H)-dione or Gö6976, specific PKC-beta and -alpha inhibitors, respectively, did not.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814638.RANC-Zikph76CyxuRqCj_FWUNLUZo8CAar5e7-a2YzKM0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP814638.RANC-Zikph76CyxuRqCj_FWUNLUZo8CAar5e7-a2YzKM0130_provenance.